Patent №
US 10,087,488
Granted
2018-10-02
Filed 2016
Owner
ALFAGENE BIOSCIENCE, INC.
Lab
—
AI components
1
planning
Assignment
Recorded
Dataset
AIPD
2023_r1 edition
Application
15050224
The described invention relates to the identification of biomarkers for gastrointestinal diseases and provides methods utilizing the biomarkers for in drug discovery, monitoring of treatment efficacy, and diagnostics. The invention further provides methods for identifying a therapeutic target to treat ulcerative colitis, colorectal cancer, and Crohn's disease.
PlanningC12Q 1/6886G01N 33/5044G01N 33/5073G01N 33/5753G01N 33/57535C12N 5/0679C12N 5/068C12Q 1/68+5 more
AI classification
Planning0.68
Machine learning0.04
Natural language0.02
AI hardware0.00
Evolutionary computation0.00
Knowledge representation0.00
Vision0.00
Speech0.00
Ownership
ALFAGENE BIOSCIENCE, INC.
assignment · 403870539
Assignors
PANJA, ASIT
On an employer assignment, the assignors are typically the inventors.